People. People who need ... Hillary?

  • by: |
  • 05/25/2007
Today's furor, as reported in the New York Times, comes from Italy where consumer groups are decrying high prices, calling them "absurd and shameful."

What they're upset about are ticket prices for the Barbara Streisand concert on June 15. (Prices range from $200 to $1200.)

The horror!

And we concur. After all, comparatively speaking, pretty good seats for the Dylan concert at Jones Beach cost under $200.

And since they're both music concerts by solo artists -- aren't they really the same thing?

Sure. Just like medicines.

That being said, consider the following from Democratic Presidential candidate, Senator Hillary Clinton, "A lot of these so-called blockbuster drugs are no more effective, and sometimes less effective, in treating conditions than old standbys."

In a speech at George Washington University, Senator Clinton said research is finding some drugs aren't worth the cost.

Really? Are some lives not worth saving?

Folks, the battle over the heart and soul of evidence-based medicine is crucial. The battle over what "comparative effectiveness" means is crucial. The battle over measurement tools is crucial.

Why? Because it's a battle between cost and care. Pols, pundits and payors are bashing life-saving medicines by using misleading metrics. And unless and until sound science raises its voice (and the media pays attention to the details) get ready for more of the same.

Ladies and gentlemen, political rhetoric is not the way to address the issue.

Unfortunately, it's rhetoric that is drving the debate and it's rhetoric that the MSM loves to report about.

But nobody said it was going to be easy.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog